Aura Biosciences Inc (AURA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -80,632 | -54,502 | -27,483 | -86,919 | -61,085 |
| Depreciation Amortization | 857 | 577 | 291 | 1,223 | 932 |
| Accounts payable and accrued liabilities | -416 | -1,018 | -298 | 482 | 172 |
| Other Working Capital | 4,413 | 2,450 | 423 | -2,642 | -1,700 |
| Other Operating Activity | 11,505 | 8,364 | 3,712 | 8,051 | 5,828 |
| Operating Cash Flow | $-64,273 | $-44,129 | $-23,355 | $-79,805 | $-55,853 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 6,042 | 50,016 | 30,000 | 70,074 | 40,080 |
| PPE Investments | -271 | -226 | -187 | -1,253 | -954 |
| Investing Cash Flow | $5,771 | $49,790 | $29,813 | $68,821 | $39,126 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 74,388 | 70,025 | 96 | 1,595 | 1,052 |
| Financing Cash Flow | $74,388 | $70,025 | $96 | $1,595 | $1,052 |
| Exchange Rate Effect | -26 | -12 | -21 | N/A | N/A |
| Beginning Cash Position | 32,461 | 32,461 | 32,461 | 41,850 | 41,850 |
| End Cash Position | 48,321 | 108,135 | 38,994 | 32,461 | 26,175 |
| Net Cash Flow | $15,860 | $75,686 | $6,533 | $-9,389 | $-15,675 |
| Free Cash Flow | |||||
| Operating Cash Flow | -64,273 | -44,129 | -23,355 | -79,805 | -55,853 |
| Capital Expenditure | -271 | -226 | -187 | -1,253 | -954 |
| Free Cash Flow | -64,544 | -44,355 | -23,542 | -81,058 | -56,807 |